GSK hires three banks to advise on potential ViiV IPO -sources

LONDON, Feb 4 (Reuters) - GlaxoSmithKline has hired Citi, Goldman Sachs and Morgan Stanley as financial advisers on its ViiV Healthcare unit as the drugmaker explores a partial initial public offering (IPO) of its HIV medicines unit, sources familiar with the matter said.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.